{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:09:15Z","timestamp":1773277755481,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["mcpiqojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings: Innovations, Quality & Outcomes"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.mayocpiqo.2018.06.004","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T11:13:02Z","timestamp":1533294782000},"page":"277-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Utility of Left Ventricular Ejection Fraction Measurements Before the Administration of Doxorubicin-Based Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma"],"prefix":"10.1016","volume":"2","author":[{"given":"Deborah L.","family":"Enns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret T.","family":"Mandelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6752-3530","authenticated-orcid":false,"given":"David M.","family":"Aboulafia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.mayocpiqo.2018.06.004_bib2","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/01.CIR.0000080946.42225.4D","volume":"108","author":"Klocke","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.mayocpiqo.2018.06.004_bib3","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting [published correction appears in J Clin Oncol. 1990;8(9):1602]","volume":"7","author":"Lister","year":"1989","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2018.06.004_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2018.06.004_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","article-title":"CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomized controlled trial by the MabThera International Trial (MInT) Group","volume":"7","author":"Pfreundschuh","year":"2006","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2018.06.004_bib6","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","article-title":"Risk factors for doxorubicin-induced congestive heart failure","volume":"91","author":"Von Hoff","year":"1979","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.mayocpiqo.2018.06.004_bib7","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2018.06.004_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00000421-200108000-00027","article-title":"Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy? Multiple gated acquisition","volume":"24","author":"Sabel","year":"2001","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2018.06.004_bib9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1200\/JOP.2012.000682","article-title":"Utility of routine left ventricular ejection fraction measurement before anthracycline-based chemotherapy in patients with diffuse large B-cell lymphoma","volume":"8","author":"Conrad","year":"2012","journal-title":"J\u00a0Oncol Pract"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2018.06.004_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clml.2014.06.026","article-title":"Utility of prechemotherapy evaluation of left ventricular function for patients with lymphoma","volume":"15","author":"Steuter","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2018.06.004_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.10201","article-title":"Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma","volume":"94","author":"Harris","year":"2002","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2018.06.004_bib14","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","article-title":"HFSA 2010 Comprehensive Heart Failure Practice Guideline","volume":"16","author":"Heart Failure Society of America","year":"2010","journal-title":"J\u00a0Card Fail"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2018.06.004_bib15","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0002-9343(87)90212-9","article-title":"Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy: seven-year experience using serial radionuclide angiocardiography","volume":"82","author":"Schwartz","year":"1987","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2018.06.004_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00000421-199704000-00005","article-title":"The role of radionuclide angiocardiography in the treatment of patients receiving doxorubicin-based chemotherapy: a reassessment","volume":"20","author":"Dreicer","year":"1997","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2018.06.004_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clbc.2011.07.006","article-title":"Routine cardiac evaluation in patients with early-stage breast cancer receiving adjuvant chemotherapy","volume":"12","author":"Jeyakumar","year":"2012","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2018.06.004_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-125-1-199607010-00008","article-title":"Anthracycline-induced cardiotoxicity","volume":"125","author":"Shan","year":"1996","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2018.06.004_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.6004\/jnccn.2011.0023","article-title":"Industry \u201crewrites\u201d of NCCN guidelines","volume":"9","author":"Carlson","year":"2011","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"19","key":"10.1016\/j.mayocpiqo.2018.06.004_bib23","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1200\/JCO.2007.14.1242","article-title":"Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin\u2019s lymphoma","volume":"26","author":"Hershman","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"34","key":"10.1016\/j.mayocpiqo.2018.06.004_bib24","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1200\/JCO.2017.72.4211","article-title":"Preexisting cardiovascular risk and subsequent heart failure among non-Hodgkin lymphoma survivors","volume":"35","author":"Salz","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.mayocpiqo.2018.06.004_bib25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2018.06.004_bib26","first-page":"e6","article-title":"Heart disease and stroke statistics\u20142013 update: a report from the American Heart Association [published corrections appear in Circulation. 2013;127(1):doi:10.1161\/CIR.0b013e31828124ad and Circulation. 2013;127(23):e841]","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"}],"container-title":["Mayo Clinic Proceedings: Innovations, Quality & Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454818300511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454818300511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:07:50Z","timestamp":1762870070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542454818300511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S2542454818300511"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2018.06.004","relation":{},"ISSN":["2542-4548"],"issn-type":[{"value":"2542-4548","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of Left Ventricular Ejection Fraction Measurements Before the Administration of Doxorubicin-Based Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings: Innovations, Quality & Outcomes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2018.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}